Concepedia

Nancy Lewis

NL

44

Publications

3.5K

Citations

29

H-Index

1988

Active since

Affiliations

Fox Chase Cancer Center(Current)

Thomas Jefferson University

The University of Texas MD Anderson Cancer Center

Geriatric Research Education and Clinical Center

University of California, Los Angeles

Nancy Lewis is an author at Fox Chase Cancer Center specializing in medicine, oncology, and cancer research.

ORCID

Top concepts

Publications per year

1988–2023

44

Publications

44

Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G<sub>1</sub> Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2

Jennifer L. Spratlin, Roger B. Cohen, Matthew Eadens et al. · Journal of Clinical Oncology · 2010 · 551 citations · Full text

Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas

Funda Meric‐Bernstam, Randy F. Sweis, F. Stephen Hodi et al. · Clinical Cancer Research · 2021 · 328 citations · Full text

Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib Study

Funda Meric‐Bernstam, Randy F. Sweis, Stefan Kasper et al. · Clinical Cancer Research · 2022 · 205 citations · Full text

Isolation and Characterization of Circulating Tumor Cells in Patients with Metastatic Colorectal Cancer

Steven J. Cohen, R. Katherine Alpaugh, Steve Gross et al. · Clinical Colorectal Cancer · 2006 · 188 citations

, , +8

Phase Ib study of MIW815 (ADU-S100) in combination with spartalizumab (PDR001) in patients (pts) with advanced/metastatic solid tumors or lymphomas.

Funda Meric‐Bernstam, Shahneen Sandhu, Omid Hamid et al. · Journal of Clinical Oncology · 2019 · 186 citations

, , +21

Rows per page

1–5 of 44